<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00688571</url>
  </required_header>
  <id_info>
    <org_study_id>BRC-CS-PMSS</org_study_id>
    <nct_id>NCT00688571</nct_id>
  </id_info>
  <brief_title>Melody Transcatheter Pulmonary Valve (TPV) Post-Market Surveillance Study</brief_title>
  <official_title>Melody TPV Post-Market Surveillance Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This non-randomized, prospective, interventional observational multi-center study is designed
      to assess the long-term clinical performance of the Medtronic Melody™ Transcatheter Pulmonary
      Valve (TPV) in the post market environment over a period of five years after transcatheter
      implantation in patients with dysfunctional RVOT conduits. In addition, the quality of life
      of implanted subjects will be assessed over five years.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Performance over five years. Freedom from the following events: * explant * reintervention * stent fracture * valve dysfunction * device or procedure related death</measure>
    <time_frame>August 2014</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>August 2014</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of device and procedure related adverse events</measure>
    <time_frame>August 2014</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic Performance</measure>
    <time_frame>August 2014</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Heart Valve Diseases</condition>
  <arm_group>
    <arm_group_label>Melody TPV Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Melody Transcatheter Pulmonary Valve implanted into a dysfunctional RV-PV conduit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Melody Transcatheter Pulmonary Valve</intervention_name>
    <description>Transcatheter valve implantation into a RV-PA conduit in patients with complex congenital heart defects where the conduit has become dysfunctional and where the patient needs intervention</description>
    <arm_group_label>Melody TPV Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Prospective subjects have complex congenital heart defects that have been palliated with
        RVOT conduits that have become dysfunctional and have a clinical indication for invasive
        intervention. Prospective subjects must meet all of following inclusion and exclusion
        criteria:

        Inclusion Criteria:

          -  Age greater than or equal to 5 years of age

          -  Weight greater than or equal to 30 kilograms

          -  Existence of a full (circumferential) RVOT conduit that was equal to or greater than
             16 mm in diameter when originally implanted

          -  Any of the following by transthoracic echocardiography

        For patients in NYHA Classification II, III, or IV:

          -  Moderate (3+) or severe (4+) pulmonary regurgitation, or

          -  Mean RVOT gradient greater than or equal to 35 mmHg.

        For patients in NYHA Classification I:

          -  Severe (4+) pulmonary regurgitation with RV dilatation or dysfunction, or

          -  Mean RVOT gradient greater than or equal to 40 mmHg.

        Exclusion Criteria:

          -  Active endocarditis

          -  A major or progressive non-cardiac disease (e.g. liver failure, renal failure, cancer)
             that results in a life expectancy of less than one year

          -  Patient or - for patients who cannot legally give consent themselves- the guardian
             unwilling or unable to provide written informed consent or comply with follow-up
             requirements

          -  Obstruction of the central veins (including the superior and inferior vena cava,
             bilateral iliac veins) such that the delivery system cannot be advanced to the heart
             via transvenous approach from either femoral vein or internal jugular vein

          -  Known intravenous drug abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Hess, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Herzzentrum München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felix Berger, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lars Soendergaard, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Giulia Gagliardi, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Bambino Gesu Rome</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Suarez de Lezo, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Reina Sofia Cordoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lee Benson, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maarten Witsenburg, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>München</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Bambino Gesu Roma</name>
      <address>
        <city>Rome</city>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Reina Sofia</name>
      <address>
        <city>Cordoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2008</study_first_submitted>
  <study_first_submitted_qc>June 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2008</study_first_posted>
  <last_update_submitted>October 28, 2015</last_update_submitted>
  <last_update_submitted_qc>October 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary Valve</keyword>
  <keyword>Congenital Heart Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

